SCHEMBL23974261

SCHEMBL23974261

O=CNc1ccc(C(F)(F)F)c(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.46
CCNE2 O96020 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
MAPT P10636 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
LMNA P02545 2/20 0.39
XBP1 P17861 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 2/20 0.37
EPHX1 P07099 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KIF11 P52732 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29886395 1.00 NOTUM (0.46) NOTUMCCNE2CDK4CCND1CCNE1
SCHEMBL19287089 0.79 KIF11 (0.50) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL11845692 0.78 ALDH1A1 (0.44) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL23974249 0.78 CCNE2 (0.43) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL6898031 0.78 SLC22A12 (0.49) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL27750253 0.77 NOTUM (0.45) NOTUMMAPTMEN1KMT2ANPSR1
SCHEMBL23974264 0.77 NOTUM (0.49) NOTUMMAPTMEN1KMT2ANPSR1
SCHEMBL2658362 0.77 ALDH1A1 (0.40) CCNE2CDK4CCND1CCNE1CDK2
SCHEMBL29886486 0.77 NOTUM (0.49) NOTUMMAPTMEN1KMT2ANPSR1
SCHEMBL17805401 0.76 TAS2R14 (0.48) NOTUMCCNE2CDK4CCND1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151532-B Quinoxalindione derivatives as irreversible inhibitors of KRAS G12C muteins 北京泰德制药股份有限公司 2023-06-06 CN disclosed
CN-115151532-A Quinoxalinedione derivatives as irreversible inhibitors of KRAS G12C muteins 北京泰德制药股份有限公司 2022-10-04 CN disclosed
WO-2021219090-A1 QUINOXALINE DIONE DERIVATIVE AS IRREVERSIBLE INHIBITOR OF KRAS G12C MUTANT PROTEIN 北京泰德制药股份有限公司 (CN) 2021-11-04 WO disclosed